Joe Fiandra Access to Home Infusion Act of 2025
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
This bill, the Joe Fiandra Access to Home Infusion Act of 2025, aims to expand Medicare coverage for external infusion pumps and certain home infusion drugs. It would allow Medicare to cover these items if specific criteria are met, including professional supervision and safe administration in the patient’s home. The bill also requires Medicare to inform patients about cost-sharing options for home infusion therapy compared to other care settings.
Key provisions
- Medicare coverage for external infusion pumps and associated home infusion drugs.
- Specific criteria must be met for coverage, including professional supervision and home administration.
- The bill defines ‘qualified home infusion therapy supplier’.
- Requires a minimum infusion frequency (at least 12 times per year).
- Mandates notification to patients regarding cost-sharing for home infusion therapy.
Who is affected
- Medicare beneficiaries
- Home infusion therapy suppliers
- Healthcare professionals involved in home infusion therapy
- Pharmaceutical companies
- The Centers for Medicare & Medicaid Services (CMS)
Notable changes
- Expands Medicare coverage to include external infusion pumps and specific home infusion drugs.
- Introduces a new requirement for home infusion therapy to meet the criteria for durable medical equipment.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
7 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours